It’s Piccadilly Circus. It’s candy pink and dayglow green. It’s 19-year-old Davina Perrin being bought by the Birmingham Phoenix for £50,000 a couple of years after she has graduated from Ebony Rainford Brent’s ACE programme. It’s the former Leicestershire fast bowler Charles Dagnall in skinny jeans with an iPad and an interactive screen. It’s Hero Players. It’s Vitality Wild Cards. It’s Sophie Devine and Beth Mooney being signed for £210,000, which is more than the entire women’s squad earned between them when the Hundred launched in 2021. It’s English cricket’s first player auction. It’s that Richard Madley off Bargain Hunt with a gavel and a silk handkerchief in his top pocket, it’s a grand total of 2,667 people watching a YouTube live stream. It’s the teams’ in-house content creators filming TikTok interviews with their bosses in a “brand performance space” at the centre of a part of London no Londoners go to unless they absolutely have to. It’s the bright, brilliant, inclusive future of English cricket. And it’s a room full of men sitting around weighing the relative merits of young women so they can bid against each other for their services in a competitive auction. Wait. Is that last one right? Unfortunately, yes. It was a historic day for female cricket players. England’s Dani Gibson has become one of the best-paid sportswomen in the country after being brought for £190,000. But it wasn’t a historic day for female cricket coaches, analysts, administrators or franchise owners, who were mostly missing from the scene. Among the 60-odd people in the room, a dozen of them were women and two of the team’s tables were entirely male. Whichever way you cut it, it was an odd look on the first day of the new era of the competition. “It is really disappointing seeing one female senior coach in this competition,” said that one female senior coach, MI London’s Lisa Keightley. “I hope that changes over time. There’s some really good female coaches that will be disappointed...

青馬大橋十車串燒釀9傷 往機場全線中午解封 司機：後車收掣不及 【有線新聞】青馬大橋十車相撞，九人輕傷，有夾在中間的車輛翻側，兩條行車線受影響，往機場路面交通一度嚴重擠塞，至中午全線恢復行車。

FHD-909 (LY4050784) Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung cancer (NSCLC) Selective CBP degrader program with potential in ER+ breast cancer tracking to IND-enabling studies in 2026 Selective EP300 degrader program tracking to IND-enabling studies in 2026 with a focus in multiple myeloma (MM) and diffuse large b-cell lymphoma (DLBCL) Completed a $50 million registered direct financing in January 2026 Strong balance sheet with cash, cash equivalents, and marketable securities of $158.9 million as of December 31, 2025; with the addition of the January 2026 financing, the company has cash runway into the first half of 2028 WATERTOWN, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today provided a financial and corporate update in conjunction with the Company’s 10-K filing for the year ending December 31, 2025. With an initial focus in oncology, Foghorn’s Gene Traffic Control® Platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases. “We are building meaningful momentum as we further advance our first-in-class portfolio of potential medicines targeting cancers with significant unmet needs,” said Adrian Gottschalk, President and Chief Executive Officer of Foghorn. “Our lead candidate FHD-909 continues to progress as planned through dose escalation in collaboration with Lilly. The trial is enriching for NSCLC patients with SMARCA4 mutations, where outcomes remain especially poor and deteriorate with later lines of therapy. In parallel, our wholly owned programs are moving toward the clinic. Our Selective CBP degrader program and our Selective EP300 degrader are on track for IND-enabling studies in 2026. Our recent cash infusion strengthen...

Stitch Fix press release ( SFIX ): Q2 GAAP EPS of -$0.02 beats by $0.03 . Revenue of $341.3M (+9.4% Y/Y) beats by $8.51M . Financial Outlook Stitch Fix’s financial outlook for the third quarter of fiscal 2026, ending May 2, 2026, is as follows: Q3 2026 Net Revenue $330 million - $335 million 1.5% - 3.1% YoY Adjusted EBITDA $7 million - $10 million 2.1% - 3.0% margin Click to enlarge The Company’s fiscal year is a 52-week or 53-week period ending on the Saturday closest to July 31. The fiscal years 2025 and 2026 are 52-week years. Stitch Fix’s updated financial outlook for fiscal year 2026 is as follows: Fiscal Year 2026 Net Revenue $1.330 billion - $1.350 billion 5.0% - 6.5% YoY Adjusted EBITDA $42 million - $50 million 3.2% - 3.7% margin Click to enlarge The Company expects full fiscal year 2026 gross margin to be between 43% and 44%. It expects full fiscal year 2026 advertising expense as a percentage of revenue to be between 9% and 10%. It also expects to be free cash flow positive for the full year. Shares +3.33% AH. More on Stitch Fix Stitch Fix: In Need Of Improved Turnaround Momentum Stitch Fix Will Not Leverage Margins This Year, And Trades Ahead Of Fundamentals Stitch Fix: Fundamental Improvements Ignored Stitch Fix Q2 2026 Earnings Preview Seeking Alpha’s Quant Rating on Stitch Fix

格隆汇3月12日｜市场消息：苹果(AAPL.O)的可折叠式iPhone计划于今年晚些时候上市。

北京时间3月12日凌晨，美股周三收盘涨跌不一。市场继续关注美以伊战争局势发展、油价走势。伊朗无人机袭击阿曼最大石油储存设施，使投资者担忧战事扩大并演变成一场扰乱全球石油供应的全面对抗。 道指跌289.24点，跌幅为0.61%，报47417.27点；纳指涨19.03点，涨幅为0.08%，报22716.13点；标普500指数跌5.68点，跌幅为0.08%，报6775.80点。 周三，伊朗无人机袭击了阿曼塞拉莱港的石油储存设施，这是针对海湾地区能源基础设施的最新一次攻击。投资者担心中东地区战争将扩大，并演变成一场围绕全球石油供应的全面对抗。 据海上安全公司安布里和阿曼官方媒体报道，港口的燃料储存罐在袭击中被击中，但该地区的商船没有受损。 西得克萨斯中质原油期货上涨4%，至每桶86美元左右。布伦特原油期货也上涨4%，至每桶91美元。即便在国际能源署表示将释放4亿桶石油（其历史上最大规模的储备释放）以应对战争引发的供应中断之后，油价仍出现上涨。 莱尔德诺顿韦瑟比公司首席投资官罗恩·阿尔巴哈里表示，国际能源署的决定“并不能解决将影响全球经济的其他问题”。他提到，通过霍尔木兹海峡运输的精炼产品（如航空燃油）就是带来的问题之一。 他对媒体表示：“我认为市场正在纠结如何找到出路的问题。双方都顽固己见，短期内很难看到此事会有积极的结局。” 冲突持续可能会使油价保持高位。周二，在德黑兰试图在霍尔木兹海峡——这条关乎石油供应的关键航道——布雷后，美国军队在该海峡附近击沉了多艘伊朗舰船，其中包括16艘布雷艇。 英国海上贸易行动办公室周三也表示，伊朗海岸附近的三艘货船（其中一艘位于霍尔木兹海峡）遭到了炮弹袭击。 而就在几天前，唐纳德·特朗普总统本周早些时候表示，战争将“很快”结束。 巴克莱银行欧洲股票策略主管伊曼纽尔·考在周三的一份报告中写道：“特朗普暗示战争可能很快结束，是在石油波动性异常飙升之后，这在我们看来意味着他的‘忍受极限’已经到了。”“油价飙升持续的时间越长，盈利和估值面临的下行风险就越大。” 美国2月份消费者价格指数同比上涨2.4%，符合 道琼斯 调查的经济学家预期。这份报告发布之前，近几个月来劳动力市场疲软的迹象日益增多。 甲骨文 公司股价周三成为一大亮点，在软件供应商的第三财季盈利和收入超出分析师预期后，其股价跃升10%。该公司还上调了2027财年的收入预测。 美国财政部周三...

特朗普谈战略石油储备：我们会稍微削减一下。 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

格隆汇3月12日｜欧盟警告称，伊朗冲突可能会导致该地区通胀超过3%。

Bumble press release ( BMBL ): Q4 GAAP EPS of -$4.06. Revenue of $224.17M (-14.3% Y/Y) beats by $2.72M . Bumble anticipates the following results for the first quarter ending March 31, 2026: First Quarter 2026: Total Revenue in the range of $209 million to $213 million, which includes: Bumble App Revenue of $171 million to $174 million. Adjusted EBITDA of $76 million to $80 million. Shares +11.62% AH. More on Bumble Bumble: TRA Settlement And Upcoming Earnings Set The Stage For Upside Bumble: I See Only One Way Out Bumble Q4 2025 Earnings Preview Bumble, Match, Panera Bread, and CrunchBase hit by cyberattacks, Bloomberg reports Seeking Alpha’s Quant Rating on Bumble

Prot Tachapanit/iStock via Getty Images Many times, when companies report financial results for their fiscal quarters, the market sends shares up or down quite a bit. It's rare, or at least I would say uncommon, for shares of the company to remain more or less flat after results come out. But that was the case with ABM Industries Incorporated ( ABM ) on March 11th after the management team at the firm announced results for the first quarter of the company's 2026 fiscal year. Revenue actually did come in comfortably above expectations . But unfortunately, earnings per share and adjusted earnings per share ended up being worse. Overall profitability for the company has been mixed but slightly negative. But one thing that is helping the enterprise is the fact that shares are priced at incredibly low levels. That helps to create a buffer, even when some financial data is worse than expected. In my last article about the company, published in December of 2025, I reaffirmed it as a Buy candidate. I found myself impressed with its strong organic and acquisition-driven growth. There were some weak spots that the company had seen. But at that time, management was working on a cost-cutting program aimed at slashing $35 million in annual run rate expenses from the business. My overall view was that, over the long run, the stock would outperform the broader market as measured by the S&P 500 ( SP500 ). And since then, we have seen it essentially match the market, with shares trading down 1.3% while the market is down 1.5%. Even though we have seen some weakness, it's likely that 2026 as a whole will be a good time for the business. And that is why I have no problem maintaining it as a Buy candidate right now. A Mixed Bag When it comes to revenue, the first quarter of the 2026 fiscal year was actually really positive for ABM Industries. Sales came in at $2.24 billion. In addition to coming in above the $2.11 billion that the company reported a year earlier, the sales and manageme...

The European Union warned that its inflation rate could surpass 3% this year if the war in the Middle East causes Brent oil prices to remain around $100 per barrel and gas prices stay elevated for an extended period. Under such a scenario, economic growth in 2026 would also take a hit. It would be as much as 0.4 percentage points lower than the 1.4% pace forecast late last year, the EU’s economy chief, Valdis Dombrovskis , told the bloc’s finance ministers this week, according to people familiar with the matter. In addition to oil prices, the scenario assumes European gas prices of around €75 per megawatt-hour for the rest of the year. The effect means inflation would be 0.7-1 percentage point above the 2.1% previously projected for 2026. A significant pickup in inflation could force the European Central Bank to raise interest rates in response, and traders have increased bets on such a move this year. The ECB’s next decision is on March 19, though no hike is expected then. The commissioner also warned that there could be additional downside effects on the economy from the conflict’s impact on financial markets, trade and supply chains, the people said. Outlook Clouded Dombrovskis told EU finance chiefs that indicators had recently been improving and the prospects for the economy were slightly better compared with the autumn, with growth of around 1.5% and 1.6% expected for this year and next, the people said, on condition of anonymity because the discussions were private. But that outlook is now clouded by the war in Iran, which has spread across the region. Missiles and drones have hit energy facilities in countries including Saudi Arabia and Qatar, affecting LNG and oil output. In addition, the transit of oil tankers and other goods through the key Strait of Hormuz has come to a near halt. The European Commission didn’t immediately respond to a request for comment sent by Bloomberg after working hours. Speaking to reporters on Monday, Dombrovskis said that “the i...

CALGARY, Alberta, March 11, 2026 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is pleased to announce that it has filed its audited annual financial statements (the “financial statements”) and related management’s discussion and analysis and its annual information form (the “AIF”) for the financial year ended December 31, 2025 (collectively, the “Annual Filings”). The AIF contains the reserves data and other oil and gas information as required by National Instrument 51-101 – Standards of Disclosure for Oil and Gas Activities. The financial and reserves information contained in the Annual Filings is consistent with the unaudited financial and reserves information disclosed in the press release issued by Birchcliff on February 11, 2026. The Annual Filings are available electronically on the Corporation’s website at www.birchcliffenergy.com and on SEDAR+ at www.sedarplus.ca. Chris Carlsen, President and Chief Executive Officer of Birchcliff, commented: “2025 was a very successful year for Birchcliff, as we executed our disciplined capital program and delivered strong operational and financial results, achieving record annual average production, while we significantly reduced our indebtedness. Looking ahead, we continue to be focused on profitable production growth, strengthening our balance sheet and paying a sustainable dividend to our shareholders. Our 2026 guidance remains unchanged and our capital program has been designed with the flexibility to adjust as needed in response to commodity prices. We are benefiting from our natural gas marketing diversification, with 54% of our natural gas production in 2026 anticipated to be effectively sold in the NYMEX HH and Dawn sales markets, and being fully unhedged on natural gas, oil and NGLs production allows us to fully participate in any commodity price strengthening this year. In addition, we are encouraged by the continued progress at our Elmworth asset. In February 2026, we c...

格隆汇3月12日｜道琼斯指数3月11日（周三）收盘下跌289.24点，跌幅0.61%，报47417.27点； 标普500指数3月11日（周三）收盘下跌5.68点，跌幅0.08%，报6775.80点； 纳斯达克综合指数3月11日（周三）收盘上涨19.03点，涨幅0.08%，报22716.13点。

据知情人士透露，苹果公司即将推出的折叠屏iPhone将包含iOS操作系统更新，首次实现类似iPad的布局和应用并排显示功能。该设备将配备一个尺寸约为iPad mini大小的内部折叠显示屏，以及一个尺寸约为小屏iPhone显示屏大小的外屏。折叠屏iPhone将运行标准iOS系统，并能并排显示两个应用，但它无法直接运行现有的iPad应用，也不支持像iPad mini那样同时开启多个窗口。（彭博） 风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状况。据此投资，责任自负。

Frequency Electronics ( FEIM ) on Wednesday said it has been awarded two contracts for satellite programs with a combined value of about $45 million. The company said one contract relates to its traditional space satellite programs, while the other is tied to proliferated satellite systems. Frequency Electronics expects the new business to begin entering its funded backlog in its fiscal fourth quarter of 2026. The company also said it anticipates additional contract awards of similar magnitude later this year. FEIM -6.64% after hours to $51.38. Source: Press Release More on Frequency Electronics Frequency Electronics: The Growth Story Is Just Beginning Frequency Electronics, Inc. (FEIM) Q2 2026 Earnings Call Transcript Frequency Electronics outlines $100M+ backlog target as defense and space growth accelerates Seeking Alpha’s Quant Rating on Frequency Electronics Historical earnings data for Frequency Electronics

Astera Labs to Participate in the 38th Annual Roth Conference Bluefield Daily Telegraph

Apple Inc. ’s forthcoming foldable iPhone will include updates to the iOS operating system that enable iPad-like layouts and side-by-side apps for the first time, enhancing the device’s appeal for multitasking. The product — Apple’s long-awaited entry into the category — will feature an interior foldable display roughly the size of an iPad mini, according to people with knowledge of the matter. There also will be an external screen that’s about the size of the display on a small iPhone. The inside display will use a wide aspect ratio, a departure from the narrower formats of foldable phones currently on the market. That should be a key selling point, according to the people, who asked not to be identified because the project is still under wraps. Apple is under pressure to show it can bring new life to this format. The arrival of the foldable iPhone this fall will come seven years after chief rival Samsung Electronics Co. launched its first model. The Apple design is intended to make the device more appealing for watching video, the people said. It also should be easier for developers to redesign their iPhone apps to more closely resemble iPad software. A spokesperson for Cupertino, California-based Apple declined to comment. Read More: Apple’s iPhone Overhaul Will Reduce Its Reliance on Annual Fall Spectacle Apple is developing new iOS app layouts and revamping its core iPhone programs to add sidebars along the left edge of the screen, similar to many of its iPad apps. Developers will also be able to adapt their iPhone software for the new interface, which will use proportions similar to an iPad in landscape mode. Despite offering an iPad-like app experience, the foldable iPhone will run the standard iOS — not iPadOS, the company’s tablet operating system. This means it will retain a simpler multitasking system, rather than adopting the more desktop-like interface introduced in iPadOS 26. It also won’t run existing iPad apps out of the box. While the foldable iPhon...

Key Takeaways Shares of Oracle soared on Wednesday after a strong earnings report that signaled AI demand remains healthy, boosting semiconductor stocks. Signs of strong AI demand, however, were not enough for the broader market—and most AI stocks—to overcome headwinds from soaring oil prices. AI optimism can only do so much for this stock market. Oracle (ORCL) stock soared Wednesday after the software and cloud computing giant topped quarterly earnings estimates and upped its revenue guidance. Oracle’s backlog—the financial metric that cemented its place in the AI conversation last year—grew $29 billion sequentially. That reinvigorated investor interest in the shares, though it didn't do as much for a broader market already up to its eyeballs in risk. The company's latest quarter should lay the foundation for regaining investor trust after the last one gave them less confidence "in the company's ability to execute (and finance) to an aggressive set of targets,” wrote Morgan Stanley analysts Wednesday. Investors grew wary of Oracle stock last year as they debated whether the company’s growth was too dependent on one big, unprofitable customer—OpenAI. They also worried the company would need to bury itself in debt to convert its backlog into revenue. Why This Matters AI optimism has repeatedly helped propel the stock market through thickets of uncertainty over the past few years. But Oracle’s strong results were failing to infuse markets with bullishness on Wednesday, suggesting the accumulation of economic and geopolitical headwinds has raised the bar for AI stocks. Oracle’s results reassured Wall Street that demand for its AI infrastructure is broad. The company raised its 2027 fiscal year revenue guidance to $90 billion from $85 billion in October. “It's worth noting that the better outlook was not attributed to any single AI enterprise deal, rather multiple contracts,” wrote Bank of America analysts on Wednesday. “This suggests Oracle is benefitting from ramping ...

Key Takeaways Shares of Oracle soared on Wednesday after a strong earnings report that signaled AI demand remains healthy, boosting semiconductor stocks. Signs of strong AI demand, however, were not enough for the broader market—and most AI stocks—to overcome headwinds from soaring oil prices. Get personalized, AI-powered answers built on 27+ years of trusted expertise. ASK AI optimism can only do so much for this stock market. Oracle (ORCL) stock soared Wednesday after the software and cloud computing giant topped quarterly earnings estimates and upped its revenue guidance. Oracle’s backlog—the financial metric that cemented its place in the AI conversation last year—grew $29 billion sequentially. That reinvigorated investor interest in the shares, though it didn't do as much for a broader market already up to its eyeballs in risk. The company's latest quarter should lay the foundation for regaining investor trust after the last one gave them less confidence "in the company's ability to execute (and finance) to an aggressive set of targets,” wrote Morgan Stanley analysts Wednesday. Investors grew wary of Oracle stock last year as they debated whether the company’s growth was too dependent on one big, unprofitable customer—OpenAI. They also worried the company would need to bury itself in debt to convert its backlog into revenue. Why This Matters AI optimism has repeatedly helped propel the stock market through thickets of uncertainty over the past few years. But Oracle’s strong results were failing to infuse markets with bullishness on Wednesday, suggesting the accumulation of economic and geopolitical headwinds has raised the bar for AI stocks. Oracle’s results reassured Wall Street that demand for its AI infrastructure is broad. The company raised its 2027 fiscal year revenue guidance to $90 billion from $85 billion in October. “It's worth noting that the better outlook was not attributed to any single AI enterprise deal, rather multiple contracts,” wrote Bank of...

Delivers financial performance above guidance ranges Full year 2025 worldwide net sales totaled $1 billion Full year gross margin expands 390 basis points to 56.1% Full year operating loss of $19 million and operating margin of (1.9)%; adjusted operating income of $12 million and adjusted operating margin of 1.1% Unveils next evolution of turnaround plan and raises long-term financial targets RICHARDSON, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the fourth quarter and fiscal year ended January 3, 2026. “The bold initiatives under the Turnaround Plan we announced one year ago gained traction quickly, enabling us to deliver operating and financial performance above our expectations for 2025,” said Franco Fogliato, CEO. “We focused on our core brands, channels and geographies, improved our cost structure and strengthened our balance sheet. We have more work ahead, but we have entered 2026 from a position of strength, with sustained momentum.” “As we continue to advance our brand-led, consumer-focused operating model, we are entering the next evolution of our Turnaround Plan - designed to return the Company to top line growth, meaningfully improve profitability and build long-term shareholder value.” Fourth Quarter 2025 Operating Results Amounts referred to as “adjusted” as well as “constant currency” are non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to their closest reported GAAP measures are included at the end of this press release. Net sales totaled $280.5 million, a decrease of 18.1% on a reported basis and 19.8% in constant currency compared to $342.3 million in the fourth quarter of fiscal 2024. The year-over-year decline was largely driven by the Company’s return to a full price selling model, as well as the previously disclosed shift of certain wholesale shipments from the fourth quarter into the third quarter of 2025. Additionally, store rationalization ...

HighPeak Energy press release ( HPK ): Q4 Non-GAAP EPS of -$0.21 misses by $0.14 . Revenue of $165.8M (-29.1% Y/Y) misses by $24.76M . Full-year 2025 average realized prices were $65.43 per Bbl of crude oil, $19.69 per Bbl of NGL and $1.25 per Mcf of natural gas, resulting in an overall realized price of $48.98 per Boe, or 75% of the weighted average of NYMEX crude oil prices, excluding the effects of derivatives. Including the effects of derivatives, full-year 2025 average realized prices were $65.82 per Bbl of crude oil, $19.69 per Bbl of NGL and $1.82 per Mcf of natural gas, resulting in an overall realized price of $49.77 per Boe. HighPeak’s cash costs for full-year 2025 were $15.33 per Boe, including lease operating costs of $6.78 per Boe, expense workovers of $1.13 per Boe, gathering, processing and transportation expenses of $3.88 per Boe, production and ad valorem taxes of $2.11 per Boe and G&A expenses of $1.43 per Boe. As a result, the Company’s unhedged EBITDAX per Boe was $33.65 per Boe. Fourth quarter average realized prices were $58.95 per Bbl of crude oil, $17.26 per Bbl of NGL and $0.17 per Mcf of natural gas, resulting in an overall realized price of $41.27 per Boe, or 70% of the weighted average of NYMEX crude oil prices, excluding the effects of derivatives. Including the effects of derivatives, fourth quarter average realized prices were $60.36 per Bbl of crude oil, $17.26 per Bbl of NGL and $0.76 per Mcf of natural gas, resulting in an overall realized price of $42.79 per Boe. HighPeak’s cash costs for the fourth quarter were $14.45 per Boe, including lease operating costs of $7.46 per Boe, expense workovers of $1.72 per Boe, gathering, processing and transportation expenses of $4.38 per Boe, production and ad valorem taxes of a negative $0.08 per Boe due to a $10 million natural gas severance tax refund recognized and G&A expenses of $0.98 per Boe. As a result, the Company’s unhedged EBITDAX per Boe was $26.81 per Boe. HighPeak’s total capital ...

格隆汇3月12日｜加拿大能源部长：加拿大政府正与业界紧急合作，评估可能的行动速度和规模，并将于未来几天公布更多信息。

Source: Bloomberg, 44:37

Xanadu Quantum Technologies Inc. is set to receive as much as C$390 million ($287 million) in government financial aid to build the engineering and domestic manufacturing capabilities for its first quantum-powered data center in Ontario, a deal that’s being negotiated just as the company is about to go public. “It’s a huge validator of our approach to build large-scale quantum computers using photonics,” Chief Executive Officer Christian Weedbrook said in an interview. Details about the money from the Canadian and Ontario governments are still being finalized, he said. Xanadu anticipates the data center will cost around $1 billion. The facility, which will be the size of three to five tennis courts, should start operating by 2030, and the firm is looking for a location in the Toronto region. Xanadu is about to go public through a deal with a blank-check company that could value the business at about $3.6 billion. The merger with Crane Harbor Acquisition Corp. is set to happen in late March, capitalizing Xanadu with about $500 million in gross proceeds, assuming no redemptions from Crane’s shareholders. Once running, the quantum-powered data center would host hundreds of server racks, helping to solve complex problems for sectors such as pharmaceuticals, materials design, chemistry, defense and finance. Thousands of data centers would be needed to achieve the same computing power Xanadu’s is expected to have, Weedbrook explained. “Once that $1 billion data center has been built, the next one after we estimate the cost around $200 to $300 million because all the R&D is essentially being done,” he said. Founded in 2016, Toronto-based Xanadu develops quantum computers powered by photons, or light particles, with scalable capabilities and that can be commercialized. Its systems run at room temperature, removing the need for the expensive cryogenic cooling required by many other quantum platforms. The company will be listed on Nasdaq and the Toronto Stock Exchange. Existi...

PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory solid tumors PLN-101095 accelerated development plan underway with initiation of Phase 1b indication expansion trial SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today provided a corporate update and reported fourth quarter 2025 financial results. “We ended 2025 with encouraging data from our lead oncology program in ICI-refractory patients, an area of unmet medical need, that informed the initiation of our accelerated development plan for PLN-101095,” said Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer of Pliant. “In addition to oncology and the early-stage pipeline programs emerging from Pliant's proprietary integrin platform, we continue to assess opportunities to expand our clinical-stage pipeline that leverage our areas of expertise and align with creating shareholder value.” Fourth Quarter and Recent Developments Oncology Program PLN-101095 is an oral, small molecule, dual selective inhibitor of αvβ8 and αvβ1 integrins designed to overcome checkpoint resistance by blocking TGF-β activation in the tumor microenvironment. Pliant is currently conducting a Phase 1a/1b open-label, dose-escalation and indication expansion trial to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of PLN-101095, as monotherapy and in combination with pembrolizumab, in patients with immune checkpoint inhibitor (ICI)-refractory advanced or metastatic solid tumors. Data from the Phase 1 trial of PLN-101095 showed deep and durable ongoing responses. In December, the Company announced positive data showing that, in a heavily pretreated patient population, PLN-101095 demonstrated anti-tumor activity in combination with pembrolizumab, an FDA-approved IC...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory Alignment for Each Program Planned in 2026 New Research Supports TN-301’s Potential in Multiple Indications; Presented Preclinical Data for TN-301 in Duchenne Muscular Dystrophy Model Entered into Multi-Target Research Collaboration with Alnylam Pharmaceuticals December Financing with Net Proceeds of $55.8M and Anticipated Upfront Payment Extend Cash Runway into Second Half of 2027 SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update. “As we enter 2026, we are energized by the momentum and clinical advances achieved over the past year,” said Faraz Ali, Chief Executive Officer of Tenaya. “The encouraging data presented in 2025 from both of our lead gene therapy programs underscore the transformative potential of our science. In the first half of 2026, we expect to share additional updates, including longer-term follow-up data from the MyPEAK™-1 clinical trial of TN-201 for MYBPC3-associated HCM, as well as one-year Cohort 1 data and early Cohort 2 data from the RIDGE™-1 clinical trial of TN-401 for PKP2-associated ARVC. Over the course of the year, we also plan to pursue regulatory agency alignment on pivotal trial plans for both programs, a critical step toward accelerating the delivery of safe and effective gene therapies to patients with serious cardiac conditions.” Mr. Ali continued, “We are also excited to take modest but important steps to move TN-301 -- our clinical-stage, highly selective, small molecule HDAC6 inhibitor -- forward towards patients. New preclinical data in relev...

CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six- months of fiscal year 2026. Second Quarter Year to Date (in thousands, except per share amounts) Ended January 31, Ended January 31, 2026 2025 Change 2026 2025 Change Consolidated Results Net Sales $ 117,737 $ 116,914 1 % $ 238,223 $ 244,859 (3)% Income from Operations * $ 15,693 $ 17,482 (10)% $ 32,647 $ 38,672 (16)% Net Income $ 12,569 $ 12,921 (3)% $ 28,025 $ 29,297 (4)% EBITDA † $ 21,735 $ 22,216 (2)% $ 45,376 $ 48,383 (6)% Diluted EPS - Common $ 0.87 $ 0.89 (2)% $ 1.93 $ 2.01 (4)% Business to Business Net Sales $ 41,977 $ 43,416 (3)% $ 86,263 $ 91,831 (6)% Segment Operating Income $ 11,799 $ 14,322 (18)% $ 25,433 $ 31,432 (19)% Retail and Wholesale Net Sales $ 75,760 $ 73,498 3% $ 151,960 $ 153,028 (1)% Segment Operating Income $ 10,772 $ 11,328 (5)% $ 23,171 $ 24,705 (6)% * Comprised of Consolidated Operating Income less unallocated corporate expenses. † Please refer to Reconciliation of Non-GAAP Financial Measures below for a reconciliation of Non-GAAP items to the comparable GAAP measures. Daniel S. Jaffee, President and Chief Executive Officer, stated, “Second quarter results were consistent with the expectations we set at the end of fiscal year 2025, as we faced another quarter of challenging year-over-year comparisons. Additionally, a severe weather event temporarily disrupted operations at several of our plants and delayed shipments at the end of the quarter, resulting in an expected meaningful shift of revenues into the next reporting period. Even with these headwinds, we delivered the highest second quarter consolidated net sales in our history, boosted by the strength of our agricultural and cat litter businesses. I am incredibly proud of our dedicated teammates who helped us navigate the winter storm and achieve full operational recovery. Our strategic ...

OMAHA, Neb., March 11, 2026 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus" or the "Company"), the leading self-custodial cryptocurrency platform and first U.S. publicly traded company to tokenize its stock, today announced its results for the fourth quarter and full year ended December 31, 2025. The Company reported record full year revenue of $121.6 million for fiscal year 2025, an increase of 5% compared to fiscal year 2024, while full year swap volume grew 21% to $6.89 billion. Fourth Quarter and Full Year 2025 Financial Highlights (In USD millions, except percentages) Q4 2025 Q4 2024 % Change 2025 2024 % Change Revenue $29.5 $44.8 (34)% $121.6 $116.3 5% Technology, development and user support $16.3 $13.2 23% $62.9 $46.0 37% General and administrative $18.3 $13.9 32% $66.3 $39.5 68% Loss (gain) on digital assets, net $63.6 $(56.9) (212)% $18.9 $(96.1) (120)% Net (loss) income $(53.2) $67.0 (179)% $(11.4) $113.0 (110)% The growth was led by its flagship B2B product, XO Swap, Exodus’ exchange aggregation product, which contributed 19% of Q4 revenue and continued to gain share as the Company builds towards becoming a core financial infrastructure for the digital asset ecosystem. B2B Infrastructure and Revenue Drivers B2B swap partners generated $416 million in Q4 volume, representing 26% of the quarterly total. XO Swap’s share of exchange volume has grown steadily since launch, reflecting demand for best-execution routing across liquidity sources. The B2B channel is also the foundation for Exodus’ next phase of growth. In November 2025, the Company announced its agreement to acquire W3C Corp ("W3C"). Upon closing, Exodus will gain the ability to issue credit cards in key jurisdictions globally through Monavate, with real-time settlement in stablecoins held in self-custody using technology from Baanx. These capabilities will be available not only to Exodus’ own users but also to its growing base of B2B partners, extending the XO Swap relat...

Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway through 2027 Completed $37.8 million Technology Transfer Agreement with Merck REDWOOD CITY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. “Throughout 2025, we made significant strides in demonstrating the importance of our ECO Synthesis® Manufacturing Platform to customers in the RNAi industry. We’ve secured multiple contracts with leading pharma, high growth biotech, and top tier CDMOs, underscoring the commercial potential of our platform,” said Alison Moore, PhD, President and Chief Executive Officer at Codexis. “We achieved many technological advancements this year, including producing a 10 g siRNA batch utilizing our fully enzymatic synthesis process, as well as a 3 kg siRNA batch from one of our customers utilizing our ligase product. As we look to the year ahead, we are focused on demonstrating the value of our technology to our customers through expanded partnerships, and continuing our history of innovation in oligonucleotide manufacturing.” Recent Business Highlights Engaging with over 40 companies on 55 potential opportunities, including existing and new customers. Our conversations throughout 2025 have evolved from feasibility testing to discussions around contracts with broader scope activities that support customer assets that are moving into preclinical and IND-enabling studies. Signed a lease on our GMP facility, which, once operational, will be capable of kilogram scale manufacturing utilizing our ECO Synthesis platform. Signed an agreement with Axolabs, our third CDMO partnership, to evaluate our ECO Syn...

ARR increased 31% year-over-year to $811 million Q4 revenue increased 32% year-over-year to $196.3 million Q4 net cash provided by operating activities was $18.1 million, representing 9% of revenue SANTA CLARA, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Netskope, Inc. (NASDAQ:NTSK) a leader in modern security and networking for the cloud and AI era, today announced financial results for the fourth quarter and fiscal year 2026, ended January 31, 2026. “We closed fiscal 2026 on a strong note, delivering record net new ARR in Q4 and achieving our first full year of positive free cash flow,” said Sanjay Beri, CEO of Netskope. “The AI Supercycle is here, demanding a new standard for high-performance security and networking. We believe the next decade will be defined by an intelligent edge. Our Netskope One platform combined with our NewEdge network is exactly that - a structural architecture built specifically for the requirements of an autonomous, agentic economy. This AI-native foundation provides the real-time context and policy enforcement needed to move beyond simple visibility and take immediate, automated action across our global fabric. With today’s launch of our new AI Security products and our recently announced AI Fast Path, we are providing the foundation to both secure and accelerate the AI world. By unifying high-speed performance with active protection, Netskope is providing the essential, adaptive fabric that empowers the modern enterprise to innovate with confidence and scale without compromise." Fourth Quarter Fiscal 2026 Financial Highlights Annual Recurring Revenue (ARR): ARR grew 31% year-over-year to $811 million as of January 31, 2026. ARR grew 31% year-over-year to $811 million as of January 31, 2026. Revenue: Q4 revenue was $196.3 million, an increase of 32% year-over-year. Q4 revenue was $196.3 million, an increase of 32% year-over-year. Gross Profit and Margin: GAAP gross profit was $143.3 million, compared to $99.3 million for the fourth quart...